Back to OpenRounds
OpenRounds Editorial

Daily Briefing

Friday, April 24, 2026

What Changed

OpenAI directly enters clinical workflows with verified physician access while breakthrough research shows LLM explanations measurably improve radiologist accuracy, forcing immediate enterprise AI strategy decisions [1][2].

Research

[Horizon: Now] Chain-of-thought explanations from LLMs improve radiologist diagnostic accuracy by 12.2% compared to no support in a randomized trial of 2,020 assessments, outperforming both standard AI outputs and differential diagnosis formats [2]. Radiology departments gain validated evidence that explanation quality, not just diagnostic suggestions, drives clinical AI effectiveness. Results demonstrate measurable workflow benefits beyond efficiency metrics.
[Horizon: Near-term] NeuroSTORM foundation model, pretrained on 28.65 million fMRI frames from 50,000+ participants, outperforms existing methods in neurological diagnosis and phenotype prediction across diverse clinical cohorts [3]. Neurology and psychiatry services get broad-spectrum fMRI analysis capabilities that could standardize functional brain imaging interpretation. Nature Biomedical Engineering validation provides strong technical foundation but clinical implementation pathways remain undefined.

Industry & Products

[Horizon: Now] OpenAI launches free ChatGPT for Clinicians with verified access for U.S. Physicians, nurse practitioners, and pharmacists, marking the AI giant's direct healthcare market entry [1]. Health systems face immediate decisions on enterprise AI governance as clinicians gain independent access to OpenAI's clinical-specific tools. Data governance, liability frameworks, and vendor relationship strategies require urgent review for direct clinician-OpenAI engagement.

Policy & Ops

[Horizon: Now] Healthcare professionals increasingly debate accountability frameworks as AI systems take larger roles in clinical decision-making, with emphasis on maintaining physician responsibility despite algorithmic support [4]. Medical leadership needs clear policies on AI delegation boundaries and decision accountability chains. Professional liability and clinical governance structures must adapt to hybrid human-AI workflows without compromising patient safety standards.